Coumarins represent a large group of 1,2-benzopyrone derivatives which have been identified in many natural sources and synthetized as well. Several studies have shown that their antioxidant capacity is not based only on direct scavenging of reactive oxygen and nitrogen species (RONS) but other mechanisms are also involved. These include: a) the chelation of transient metals iron and copper, which are known to catalyse the Fenton reaction; and b) the inhibition of RONS-producing enzymes (e.g. xanthine oxidase, myeloperoxidase and lipoxygenase), suggesting that mechanism(s) involved on cellular level are complex and synergistic. Moreover, many factors must be taken into account when analysing structure-antioxidant capacity relationships of coumarins due to different in vitro/in vivo methodological approaches. The structural features necessary for the direct RONS scavenging and metal chelation are apparently similar and the ideal structures are 6,7-dihydroxy- or 7,8-dihydroxycoumarins. However, the clinical outcome is unknown, because these coumarins are able to reduce copper and iron, and may thus paradoxically potentiate the Fenton chemistry. The similar structural features appear to be associated with inhibition of lipoxygenase, probably due to interference with iron in its active site. Contrarily, 6,7-dihydroxycoumarin seems to be the most active coumarin in the inhibition of xanthine oxidase while its derivative bearing the 4-methyl group or 7,8-dihydroxycoumarin are less active or inactive. In addition, coumarins may hinder the induction of inducible NO-synthase and cyclooxygenase- 2. Sparse data on inhibition of myeloperoxidase do not enable any clear conclusion, but some coumarins may block it.

Department of Pharmacology and Toxicology Faculty of Pharmacy in Hradec Krelove Charles University Prague Heyrovskeho 1203 500 05 Hradec Kralove Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc16000317

003      

CZ-PrNML

005      

20160122131011.0

007      

ta

008      

160108s2015 ne f 000 0|eng||

009      

AR

024    7_

$a 10.2174/1568026615666150206152233 $2 doi

035    __

$a (PubMed)25658804

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ne

100    1_

$a Filipský, Tomáš

245    10

$a Antioxidant effects of coumarins include direct radical scavenging, metal chelation and inhibition of ROS-producing enzymes / $c T. Filipský, M. Říha, K. Macáková, E. Anzenbacherová, J. Karlíčková, P. Mladěnka,

520    9_

$a Coumarins represent a large group of 1,2-benzopyrone derivatives which have been identified in many natural sources and synthetized as well. Several studies have shown that their antioxidant capacity is not based only on direct scavenging of reactive oxygen and nitrogen species (RONS) but other mechanisms are also involved. These include: a) the chelation of transient metals iron and copper, which are known to catalyse the Fenton reaction; and b) the inhibition of RONS-producing enzymes (e.g. xanthine oxidase, myeloperoxidase and lipoxygenase), suggesting that mechanism(s) involved on cellular level are complex and synergistic. Moreover, many factors must be taken into account when analysing structure-antioxidant capacity relationships of coumarins due to different in vitro/in vivo methodological approaches. The structural features necessary for the direct RONS scavenging and metal chelation are apparently similar and the ideal structures are 6,7-dihydroxy- or 7,8-dihydroxycoumarins. However, the clinical outcome is unknown, because these coumarins are able to reduce copper and iron, and may thus paradoxically potentiate the Fenton chemistry. The similar structural features appear to be associated with inhibition of lipoxygenase, probably due to interference with iron in its active site. Contrarily, 6,7-dihydroxycoumarin seems to be the most active coumarin in the inhibition of xanthine oxidase while its derivative bearing the 4-methyl group or 7,8-dihydroxycoumarin are less active or inactive. In addition, coumarins may hinder the induction of inducible NO-synthase and cyclooxygenase- 2. Sparse data on inhibition of myeloperoxidase do not enable any clear conclusion, but some coumarins may block it.

650    _2

$a chelátory $x chemie $x metabolismus $x farmakologie $7 D002614

650    _2

$a měď $x chemie $x metabolismus $7 D003300

650    _2

$a kumariny $x chemie $x metabolismus $x farmakologie $7 D003374

650    _2

$a cyklooxygenasa 2 $x metabolismus $7 D051546

650    _2

$a inhibitory enzymů $x chemie $x metabolismus $x farmakologie $7 D004791

650    _2

$a scavengery volných radikálů $x chemie $x metabolismus $x farmakologie $7 D016166

650    _2

$a lidé $7 D006801

650    _2

$a železo $x chemie $x metabolismus $7 D007501

650    _2

$a lipoxygenasa $x metabolismus $7 D008084

650    _2

$a synthasa oxidu dusnatého, typ II $x antagonisté a inhibitory $x metabolismus $7 D052247

650    _2

$a oxidační stres $x účinky léků $7 D018384

650    _2

$a peroxidasa $x antagonisté a inhibitory $x metabolismus $7 D009195

650    _2

$a reaktivní formy kyslíku $x antagonisté a inhibitory $x metabolismus $7 D017382

650    _2

$a vztahy mezi strukturou a aktivitou $7 D013329

650    _2

$a xanthinoxidasa $x antagonisté a inhibitory $x metabolismus $7 D014969

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

655    _2

$a přehledy $7 D016454

700    1_

$a Říha, Michal

700    1_

$a Macáková, Kateřina

700    1_

$a Anzenbacherová, Eva $7 stk2008428613

700    1_

$a Karlíčková, Jana

700    1_

$a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Krelove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic. mladenkap@faf.cuni.cz.

773    0_

$w MED00007896 $t Current topics in medicinal chemistry $x 1873-4294 $g Roč. 15, č. 5 (2015), s. 415-31

856    41

$u https://pubmed.ncbi.nlm.nih.gov/25658804 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20160108 $b ABA008

991    __

$a 20160122131131 $b ABA008

999    __

$a ok $b bmc $g 1102598 $s 924523

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 15 $c 5 $d 415-31 $i 1873-4294 $m Current topics in medicinal chemistry $n Curr Top Med Chem $x MED00007896

LZP    __

$a Pubmed-20160108